3 value stocks we find risky

IART Maintained by Truist Securities -- Price Target Lowered to $13.00

Truist Securities Maintains Hold on Integra Lifesciences, Lowers Price Target to $13

Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History

Integra LifeSciences (IART) Stock Sees Fair Value Cut After Analyst Target Reductions

Integra LifeSciences: Progress Remains Frustratingly Slow, But Valuation Is Getting Interesting

Citigroup Maintains Neutral on Integra Lifesciences, Lowers Price Target to $14

BMO Capital Maintains Market Perform on Integra Lifesciences, Lowers Price Target to $14

Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Lowers Price Target to $13

Citizens Maintains Market Outperform on Integra Lifesciences, Lowers Price Target to $22

JP Morgan Maintains Underweight on Integra Lifesciences, Lowers Price Target to $14

IART Q3 deep dive: Cincinnati disruption and Tissue Reconstruction challenges weigh on outlook

Integra LifeSciences (IART) Stock Price Sinks As Q3 Earnings Revive Refinancing Worries

Integra LifeSciences' $2.1B Refinancing Merits A Closer Look

Why Integra LifeSciences (IART) stock is falling today